Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Arnulf

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Brain : a Journal of Neurology|July 8, 2005
Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndromeV Cochen, I Arnulf, S Demeret, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's diseaseO Rascol, I Arnulf, H Peyro-Saint Paul, et al.
Advances in Neurology|November 22, 2002
Parkinson's disease is a neuropsychiatric disorderY Agid, I Arnulf, P Bejjani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 7, 2006
Parkinson's disease with camptocormiaF Bloch, J L Houeto, S Tezenas du Montcel, et al.
Journal of Molecular Neuroscience : MN|May 2, 2015
Parkinson's Disease Genetic Loci in Rapid Eye Movement Sleep Behavior DisorderZ Gan-Or, S L Girard, A Noreau, et al.
Neurology|June 30, 2012
Environmental risk factors for REM sleep behavior disorder: a multicenter case-control studyR B Postuma, J Y Montplaisir, A Pelletier, et al.
Sleep Medicine|March 12, 2013
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorderB F Boeve, M H Silber, T J Ferman, et al.
Sleep Medicine|July 27, 2013
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study GroupC H Schenck, J Y Montplaisir, B Frauscher, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Brain : a Journal of Neurology|July 8, 2005
Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndromeV Cochen, I Arnulf, S Demeret, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's diseaseO Rascol, I Arnulf, H Peyro-Saint Paul, et al.
Advances in Neurology|November 22, 2002
Parkinson's disease is a neuropsychiatric disorderY Agid, I Arnulf, P Bejjani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 7, 2006
Parkinson's disease with camptocormiaF Bloch, J L Houeto, S Tezenas du Montcel, et al.
Journal of Molecular Neuroscience : MN|May 2, 2015
Parkinson's Disease Genetic Loci in Rapid Eye Movement Sleep Behavior DisorderZ Gan-Or, S L Girard, A Noreau, et al.
Neurology|June 30, 2012
Environmental risk factors for REM sleep behavior disorder: a multicenter case-control studyR B Postuma, J Y Montplaisir, A Pelletier, et al.
Sleep Medicine|March 12, 2013
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorderB F Boeve, M H Silber, T J Ferman, et al.
Sleep Medicine|July 27, 2013
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study GroupC H Schenck, J Y Montplaisir, B Frauscher, et al.
Pageof 8